Dankook University researchers used a dongchimi strain to break down whey. One fraction reached about 85% calcium solubility and beat a commercial standard in one antioxidant test.
Recap by typeshit. Full story at BIOENGINEER.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Researchers at the EADV Congress found 39% of 575 GLP-1 users had nails lifting from the nail bed, versus 9% of non-users. Authors say it's a link, not proof.
A claims analysis of over 200,000 adults with type 2 diabetes shown at EASD 2026 found the gap. Outside doctors note it shows association only and may reflect adherence.
Loading…